Published by Josh White on 23rd February 2022
(Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals announced updated survival data from the phase 1 and 2 study investigating the safety and efficacy of 'bexmarilimab' on Wednesday.
URL: http://www.digitallook.com/dl/news/story/32484233/...